Green Park Pharma develops innovative (IP) formulations of trusted medicines that address critical unmet patient needs
The administration method of some licensed medicines often fails to meet patient requirements, resulting in poor adherence and unmet clinical needs. It may be that a patient can’t swallow pills, or cannot stand the taste, or a product has to be administered through a tube. In many cases, patients fail to take their medication.
In building an intellectual property portfolio, Green Park Pharma focuses on products and regions that require specialised technical/ regulatory expertise, offering enhanced market protection. They aim to provide patients and key Healthcare Professionals a licensed product that is simple to store, transport, and administer, improving outcomes for all key stakeholders.
